Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice
- PMID: 12566493
- PMCID: PMC2683253
- DOI: 10.1093/jn/133.2.516
Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice
Abstract
Although high doses of single bioactive agents may have potent anticancer effects, the chemopreventive properties of the Asian diet may result from interactions among several components that potentiate the activities of any single constituent. In Asia, where intake of soy products and tea consumption are very high, aggressive prostate cancer is significantly less prevalent in Asian men. The objective of the present study was to identify possible synergistic effects between soy and tea components on prostate tumor progression in a mouse model of orthotopic androgen-sensitive human prostate cancer. Soy phytochemical concentrate (SPC), black tea and green tea were compared with respect to tumorigenicity rate, primary tumor growth, tumor proliferation index and microvessel density, serum androgen level and metastases to lymph nodes. SPC, black tea and green tea significantly reduced tumorigenicity. SPC and black tea also significantly reduced final tumor weights. Green tea did not reduce final tumor weight, although it tended to elevate (P = 0.14) the serum dihydrotestosterone (DHT) concentration. The combination of SPC and black tea synergistically inhibited prostate tumorigenicity, final tumor weight and metastases to lymph nodes in vivo. The combination of SPC and green tea synergistically inhibited final tumor weight and metastasis and significantly reduced serum concentrations of both testosterone and DHT in vivo. Inhibition of tumor progression was associated with reduced tumor cell proliferation and tumor angiogenesis. This study suggests that further research is warranted to study the role of soy and tea combination as effective nutritional regimens in prostate cancer prevention.
Figures


Similar articles
-
Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.Prostate. 2002 Oct 1;53(2):143-53. doi: 10.1002/pros.10141. Prostate. 2002. PMID: 12242729 Free PMC article.
-
Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice.Int J Cancer. 2004 Jan 1;108(1):8-14. doi: 10.1002/ijc.11549. Int J Cancer. 2004. PMID: 14618609 Free PMC article.
-
Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice.Am J Clin Nutr. 2007 Sep;86(3):s882-8. doi: 10.1093/ajcn/86.3.882S. Am J Clin Nutr. 2007. PMID: 18265483 Free PMC article.
-
Molecular targets for green tea in prostate cancer prevention.J Nutr. 2003 Jul;133(7 Suppl):2417S-2424S. doi: 10.1093/jn/133.7.2417S. J Nutr. 2003. PMID: 12840218 Review.
-
Potential Benefits of Green Tea in Prostate Cancer Prevention and Treatment: A Comprehensive Review.Chin J Integr Med. 2024 Nov;30(11):1045-1055. doi: 10.1007/s11655-024-4100-2. Epub 2024 Apr 2. Chin J Integr Med. 2024. PMID: 38561489 Review.
Cited by
-
The Multitarget Activity of Natural Extracts on Cancer: Synergy and Xenohormesis.Medicines (Basel). 2018 Dec 28;6(1):6. doi: 10.3390/medicines6010006. Medicines (Basel). 2018. PMID: 30597909 Free PMC article. Review.
-
Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast Cancer.J Nutr. 2019 Apr 1;149(4):619-627. doi: 10.1093/jn/nxy316. J Nutr. 2019. PMID: 30926986 Free PMC article. Clinical Trial.
-
Green tea and prostate cancer: from bench to clinic.Front Biosci (Elite Ed). 2009 Jun 1;1(1):13-25. doi: 10.2741/E2. Front Biosci (Elite Ed). 2009. PMID: 19482620 Free PMC article. Review.
-
Traditional Chinese medicinal formula Si-Wu-Tang prevents oxidative damage by activating Nrf2-mediated detoxifying/antioxidant genes.Cell Biosci. 2014 Feb 10;4(1):8. doi: 10.1186/2045-3701-4-8. Cell Biosci. 2014. PMID: 24507416 Free PMC article.
-
Mitochondrial pathway mediates the antileukemic effects of Hemidesmus indicus, a promising botanical drug.PLoS One. 2011;6(6):e21544. doi: 10.1371/journal.pone.0021544. Epub 2011 Jun 28. PLoS One. 2011. PMID: 21738701 Free PMC article.
References
-
- Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J. Clin. 1999;49:8–31. - PubMed
-
- Dhom G. Epidemiological aspects of latent and clinically manifest carcinoma of the prostate. J. Cancer Res. Clin. Oncol. 1983;106:210–218. - PubMed
-
- Yatani R, Kusano I, Shiraishi T, Hayashi T, Stemmermann GN. Latent prostatic carcinoma: pathological and epidemiological aspects. Jpn. J. Clin. Oncol. 1989;19:319–326. - PubMed
-
- Muir CS, Nectoux J, Staszewski J. The epidemiology of prostate cancer. Geographic distribution and time-trends. Acta Oncol. 1991;30:133–140. - PubMed
-
- Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J. Clin. 1999;49:33–64. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical